StockData
Eton Pharmaceuticals, Inc. logo

Eton Pharmaceuticals, Inc. (ETON) stock

ETONNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30517% above fair value
$61.99−1.66 (-2.61%)

Close on Nov 18, 2026Market cap $1.77BP/E 158.9Yield –

Eton Pharmaceuticals total assets

Total assets on the balance sheet at the end of each period.

Eton Pharmaceuticals's total assets was $115.81M at Jun 30, 2026. For fiscal 2025 it was $92.11M, up 21.0% from the year before. The highest annual figure on record is $92.11M in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$92.11M+21.0%
FY2024Dec 31, 2024$76.12M+139.8%
FY2023Dec 31, 2023$31.74M+26.8%
FY2022Dec 31, 2022$25.03M-8.9%
FY2021Dec 31, 2021$27.47M+4.4%
FY2020Dec 31, 2020$26.32M+54.2%
FY2019Dec 31, 2019$17.07M-39.7%
FY2018Dec 31, 2018$28.33M+110.7%
FY2017Dec 31, 2017$13.44M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$115.81M+13.9%
Q1 FY2026Mar 31, 2026$97.71M+16.3%
Q4 FY2025Dec 31, 2025$92.11M+21.0%
Q3 FY2025Sep 30, 2025$104.51M+191.6%
Q2 FY2025Jun 30, 2025$101.68M+219.5%
Q1 FY2025Mar 31, 2025$84.03M+172.9%
Q4 FY2024Dec 31, 2024$76.12M+139.8%
Q3 FY2024Sep 30, 2024$35.84M+13.7%
Q2 FY2024Jun 30, 2024$31.82M+2.9%
Q1 FY2024Mar 31, 2024$30.79M+28.7%
Q4 FY2023Dec 31, 2023$31.74M+26.8%
Q3 FY2023Sep 30, 2023$31.53M+46.5%
Q2 FY2023Jun 30, 2023$30.93M+34.2%
Q1 FY2023Mar 31, 2023$23.93M+3.2%
Q4 FY2022Dec 31, 2022$25.03M-8.9%
Q3 FY2022Sep 30, 2022$21.52M-19.1%
Q2 FY2022Jun 30, 2022$23.05M-22.9%
Q1 FY2022Mar 31, 2022$23.20M-25.6%
Q4 FY2021Dec 31, 2021$27.47M+4.4%
Q3 FY2021Sep 30, 2021$26.61M+133.5%
Q2 FY2021Jun 30, 2021$29.91M+105.4%
Q1 FY2021Mar 31, 2021$31.19M+80.9%
Q4 FY2020Dec 31, 2020$26.32M+54.2%
Q3 FY2020Sep 30, 2020$11.40M-15.6%
Q2 FY2020Jun 30, 2020$14.56M-20.2%
Q1 FY2020Mar 31, 2020$17.24M-25.1%
Q4 FY2019Dec 31, 2019$17.07M-39.7%
Q3 FY2019Sep 30, 2019$13.51M+79.5%
Q2 FY2019Jun 30, 2019$18.24M+35.7%
Q1 FY2019Mar 31, 2019$23.02M–
Q4 FY2018Dec 31, 2018$28.33M–
Q3 FY2018Sep 30, 2018$7.53M–
Q4 FY2017Dec 31, 2017$13.44M–

More Eton Pharmaceuticals figures

See a number that looks wrong?